A detailed history of Rothschild Investment LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 4,160 shares of GILD stock, worth $401,731. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,160
Previous 5,587 25.54%
Holding current value
$401,731
Previous $383 Million 9.01%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$66.59 - $83.99 $95,023 - $119,853
-1,427 Reduced 25.54%
4,160 $349 Million
Q2 2024

Jul 30, 2024

BUY
$63.15 - $72.88 $352,819 - $407,180
5,587 New
5,587 $383 Million
Q1 2024

Jul 31, 2024

SELL
$71.58 - $87.29 $30,421 - $37,098
-425 Reduced 8.35%
4,662 $341 Million
Q4 2023

Jul 31, 2024

SELL
$73.27 - $83.09 $36,635 - $41,545
-500 Reduced 8.95%
5,087 $412 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $121B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.